Skip to main content
. 2014 Jun;99(6):1114–1122. doi: 10.3324/haematol.2013.099341

Table 3.

Cumulative dose of bortezomib delivered, overall and as a percentage of the planned total dose, and rate of completion of all planned cycles and (for VISTA and GIMEMA MM-03-05) early cycles (1–4) of bortezomib (excluding maintenance therapy).

graphic file with name 991114.tab3.jpg